FindTrial
Sign In

Clinical study investigating background factors that affect the prognosis of patients with relapsed or metastatic renal cell carcinoma

Clinical study investigating background factors that affect the prognosis of patients with relapsed or metastatic renal cell carcinoma - Clinical study investigating background factors that affect the prognosis of patients with relapsed or metastatic renal cell carcinoma (JEWEL study)

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000043415
Enrollment
770
Registered
2021-02-23
Start date
2021-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

renal cell carcinoma

Interventions

None listed

Sponsors

Chugai Pharmaceutical Co., Ltd.
Lead Sponsor
Kindai University Health Data Deep Learning Team, Medical Sciences Innovation Hub Program, RIKEN
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Database provided by ARCHERY study Refer from ARCHERY study (UMIN000034131) inclusion criteria.

Exclusion criteria

Exclusion criteria: Not applicable Refer from ARCHERY study (UMIN000034131) exclusion criteria.

Design outcomes

Primary

MeasureTime frame
OS defined as the time from initiation of first-line treatment to death.—

Secondary

MeasureTime frame
Duration of first-line treatment. OS by factor of interest. Duration of first-line treatment by factor of interest. Reasons for discontinuing first-line and second-line treatment by age.—

Countries

Japan

Contacts

Public ContactTomoko Kotani

SRL Medisearch Inc. Clinical Research Development

tomoko.kotani@hugp.com050-2000-5231

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026